Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes. [electronic resource]
Producer: 20130820Description: 2000-7 p. digitalISSN:- 1530-0277
- Adult
- Aged
- Alcohol Drinking -- drug therapy
- Alcoholism -- drug therapy
- Dopamine Plasma Membrane Transport Proteins -- genetics
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Naltrexone -- therapeutic use
- Narcotic Antagonists -- therapeutic use
- Receptors, Opioid, mu -- genetics
- Social Environment
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.